Laboratory Corporation of America Holdings (NYSE:LH) Stake Raised by Blair William & Co. IL

Blair William & Co. IL lifted its holdings in Laboratory Corporation of America Holdings (NYSE:LH) by 11.3% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,780 shares of the medical research company’s stock after purchasing an additional 180 shares during the period. Blair William & Co. IL’s holdings in Laboratory Corporation of America Holdings were worth $274,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of Laboratory Corporation of America Holdings by 2.6% in the 1st quarter. Vanguard Group Inc. now owns 10,130,291 shares of the medical research company’s stock worth $1,453,393,000 after purchasing an additional 259,182 shares during the last quarter. BlackRock Inc. grew its stake in shares of Laboratory Corporation of America Holdings by 3,602.5% in the 1st quarter. BlackRock Inc. now owns 8,074,378 shares of the medical research company’s stock worth $1,158,430,000 after purchasing an additional 7,856,297 shares during the last quarter. State Street Corp grew its stake in shares of Laboratory Corporation of America Holdings by 2.4% in the 1st quarter. State Street Corp now owns 4,639,813 shares of the medical research company’s stock worth $665,669,000 after purchasing an additional 109,170 shares during the last quarter. Boston Partners grew its stake in shares of Laboratory Corporation of America Holdings by 4.8% in the 2nd quarter. Boston Partners now owns 4,590,372 shares of the medical research company’s stock worth $707,560,000 after purchasing an additional 210,138 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its stake in shares of Laboratory Corporation of America Holdings by 0.4% in the 1st quarter. Bank of New York Mellon Corp now owns 1,347,599 shares of the medical research company’s stock worth $193,340,000 after purchasing an additional 5,743 shares during the last quarter. 93.19% of the stock is currently owned by institutional investors.

Several research analysts have commented on the stock. Craig Hallum reiterated a “buy” rating and issued a $179.00 target price (up from $157.00) on shares of Laboratory Corporation of America Holdings in a report on Thursday, July 27th. Credit Suisse Group cut shares of Laboratory Corporation of America Holdings to a “hold” rating and set a $146.00 target price for the company. in a report on Thursday, July 13th. They noted that the move was a valuation call. Zacks Investment Research upgraded shares of Laboratory Corporation of America Holdings from a “hold” rating to a “buy” rating and set a $173.00 target price for the company in a report on Thursday. Barclays PLC reiterated an “overweight” rating and issued a $182.00 target price (up from $175.00) on shares of Laboratory Corporation of America Holdings in a report on Monday, July 17th. Finally, BidaskClub upgraded shares of Laboratory Corporation of America Holdings from a “buy” rating to a “strong-buy” rating in a report on Wednesday, June 28th. Four research analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. Laboratory Corporation of America Holdings currently has an average rating of “Buy” and a consensus price target of $165.82.

In other Laboratory Corporation of America Holdings news, insider F Samuel Eberts III sold 31,500 shares of the company’s stock in a transaction that occurred on Friday, August 25th. The stock was sold at an average price of $155.22, for a total transaction of $4,889,430.00. Following the completion of the transaction, the insider now owns 31,894 shares of the company’s stock, valued at approximately $4,950,586.68. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO David P. King sold 44,687 shares of the company’s stock in a transaction that occurred on Wednesday, September 6th. The stock was sold at an average price of $156.86, for a total value of $7,009,602.82. Following the transaction, the chief executive officer now directly owns 258,753 shares of the company’s stock, valued at approximately $40,587,995.58. The disclosure for this sale can be found here. Over the last three months, insiders have sold 222,968 shares of company stock valued at $34,980,922. 0.90% of the stock is owned by company insiders.

Shares of Laboratory Corporation of America Holdings (NYSE:LH) opened at 155.07 on Friday. Laboratory Corporation of America Holdings has a 12-month low of $119.51 and a 12-month high of $164.22. The company’s 50 day moving average is $156.24 and its 200 day moving average is $147.88. The firm has a market capitalization of $15.79 billion, a PE ratio of 21.72 and a beta of 0.94.

Laboratory Corporation of America Holdings (NYSE:LH) last posted its earnings results on Wednesday, July 26th. The medical research company reported $2.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.40 by $0.07. Laboratory Corporation of America Holdings had a return on equity of 16.85% and a net margin of 7.57%. The business had revenue of $2.50 billion during the quarter, compared to analysts’ expectations of $2.47 billion. During the same period in the prior year, the business earned $2.36 EPS. Laboratory Corporation of America Holdings’s revenue for the quarter was up 4.9% compared to the same quarter last year. On average, analysts forecast that Laboratory Corporation of America Holdings will post $9.54 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “Laboratory Corporation of America Holdings (NYSE:LH) Stake Raised by Blair William & Co. IL” was posted by BBNS and is the property of of BBNS. If you are accessing this piece of content on another site, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://baseballnewssource.com/markets/blair-william-co-il-acquires-180-shares-of-laboratory-corporation-of-america-holdings-lh/1601297.html.

Laboratory Corporation of America Holdings Company Profile

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

Institutional Ownership by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)

Receive News & Ratings for Laboratory Corporation of America Holdings Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Corporation of America Holdings and related companies with our FREE daily email newsletter.

 


Latest News

American League Once Again Dominates National League
American League Once Again Dominates National League
Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22


Leave a Reply

 
© 2006-2017 BBNS.